These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 581993)

  • 1. [Inhalation therapy with the new antisecretory drug ambroxol (metabolite VIII of bromhexine) in otorhinolaryngology].
    Hoffmann H
    Arzneimittelforschung; 1978; 28(5a):931-3. PubMed ID: 581993
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evaluation of the effects of ambroxol in the surgical preparation of patients with bronchopulmonary disorders. Administration during intermittent positive pressure ventilation].
    Minuto A; Corino T; Ceccopieri M; Bardi F
    Clin Ter; 1984 Dec; 111(6):521-30. PubMed ID: 6396029
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prevention and therapy of respiratory distress syndrome in premature infants by means of bromhexine metabolite VIII. Animal experimental studies on the therapeutic efficacy of bromhexine metabolite VIII in premature respiratory distress syndrome].
    Endell W; Grosspietzsch R; Klink F; von Klitzing L; Oberheuser F
    Fortschr Med; 1977 Sep; 95(25):2145-8. PubMed ID: 242957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A controlled study on the action of a new formulation of ambroxol in asthmatiform bronchitis in children].
    Baldini G; Gucci M; Tarò D; Memmini C
    Minerva Pediatr; 1989 Feb; 41(2):91-5. PubMed ID: 2661989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical results in the treatment of chronic obstructive bronchitis with ambroxol in comparison with bromhexine (author's transl)].
    Wiessmann KJ; Niemeyer K
    Arzneimittelforschung; 1978; 28(5a):918-21. PubMed ID: 373777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Functional examination of the lungs in evaluating the effect of respiratory rehabilitation and mucolytics in cystic fibrosis].
    Zapletal A; Vávrová V; Stefanová J; Horák J; Samánek M
    Cesk Pediatr; 1983 Sep; 38(9):519-24. PubMed ID: 6640752
    [No Abstract]   [Full Text] [Related]  

  • 7. Possibility of interaction among antibiotics and mucolytics in children.
    Principi N; Zavattini G; Daniotti S
    Int J Clin Pharmacol Res; 1986; 6(5):369-72. PubMed ID: 3781700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical experience with ambroxol syrup (author's transl)].
    Göbel P; Rensch H
    Arzneimittelforschung; 1978; 28(5a):929-31. PubMed ID: 581992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of bromhexine metabolite VIII (NA 872) in an animal model of the respiratory distress syndrome.
    Dauberschmidt R; Kuckelt W; Bender V; Hieronymi U; Mrochen H; Winsel K; Zinsmeyer J; Meyer M
    Bull Eur Physiopathol Respir; 1980; 16(2):135-43. PubMed ID: 6783152
    [No Abstract]   [Full Text] [Related]  

  • 10. [Incorporation of a stimulant of the synthesis and secretion of pulmonary surfactant (ambroxol) in the medical treatment of serous otitis].
    Calero del Castillo JB; Pérez Martínez F; Piqueras Pérez F; Redondo Luciáñez ER
    An Otorrinolaringol Ibero Am; 1988; 15(2):209-18. PubMed ID: 3389499
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prophylaxis and treatment of bronchopulmonary complications with ambroxol administered by infusion in elderly patients undergoing surgery].
    Bavaro P; Biscari P
    G Chir; 1989 Oct; 10(10):605-9. PubMed ID: 2518303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of ambroxol in the therapy of neonatal respiratory insufficiency].
    Colombo ML; Dogliani P; Ulla L
    Minerva Pediatr; 1988 Jun; 40(6):333-8. PubMed ID: 3185433
    [No Abstract]   [Full Text] [Related]  

  • 13. New aspects in the treatment of pulmonary and upper airways diseases. Proceedings of the satellite symposium to the 4th Congress of the European Society of Pneumology. Milano and Stresa, September 23-28, 1985.
    Respiration; 1987; 51 Suppl 1():1-68. PubMed ID: 3602597
    [No Abstract]   [Full Text] [Related]  

  • 14. [Results of a clinical trial with ambroxol as to postoperative therapy of bronchitis (author's transl)].
    Kranicke R
    Arzneimittelforschung; 1978; 28(5a):934-5. PubMed ID: 581994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Modification of mucociliary clearance by a combination of theophylline with ambroxol and of ambroxol in monotherapy].
    Dorow P; Weiss T
    Arzneimittelforschung; 1988 Jun; 38(6):828-30. PubMed ID: 3052462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect on the mucociliary clearance of ambroxol administered via inhalation: preliminary observations].
    Olivieri D; Del Donno M; Annicelli A; Palmieri F
    Arch Monaldi; 1983; 38(4):135-40. PubMed ID: 6679252
    [No Abstract]   [Full Text] [Related]  

  • 17. The antenatal use of ambroxol (bromhexine metabolite VIII) to prevent hyaline membrane disease: a controlled double-blind study.
    Wauer RR; Schmalisch G; Menzel K; Schröder M; Müller K; Tiller R; Methfessel G; Sitka U; Koepke E; Plath C; Schlegel C; Böttcher M; Köppe I; Fricke U; Severin K; Jacobi R; Schmidt W; Hinkel GK; Nitz I; Kunze D; Reichmann G; Lachmann B; Lampe K; Grauel EL
    Int J Biol Res Pregnancy; 1982; 3(2):84-91. PubMed ID: 7042592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ambroxol in bronchopulmonary pathology in children].
    Berni M; Collina A; Zavattini G
    Clin Ter; 1983 Sep; 106(5):351-5. PubMed ID: 6641103
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of secretory otitis media with ambroxol].
    Sartoris A
    Acta Otorhinolaryngol Ital; 1987; 7 Suppl 16():51-60. PubMed ID: 3334304
    [No Abstract]   [Full Text] [Related]  

  • 20. Ambroxol for prophylaxis and treatment of bronchopulmonary complications after chest surgery.
    Romanini BM; Sandri MG; Tosi M; Mezzetti M; Mazzetti A
    Int J Clin Pharmacol Res; 1986; 6(2):123-7. PubMed ID: 3522443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.